Posts

Department of Energy funds new center for decarbonizati...

Center to develop cost-effective method for decarbonized manufacturing for steel...

Berkeley Lab awarded two new centers to counter climate...

The Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) ...

University of Cincinnati radiation oncology experts pre...

University of Cincinnati Cancer Center researchers will present abstracts at the...

University of Virginia team’s research offers hope for ...

Using a new recipe for growing blood vessels from living lung tissue in the lab,...

ASTRO 2023 Session shines spotlight on physician burnout

MIAMI, FLORIDA (EMBARGOED UNTIL SEPT. 29, 2023, AT 5 PM ET, 2023) – Physician bu...

Neural activity associated with motor commands changes ...

Standing at a crosswalk, the signal changes from “don’t walk,” to “walk.” You mi...

Hairy polymer balls help get genetic blueprints inside ...

Tokyo, Japan – Scientists from Tokyo Metropolitan University have realized a new...

New study will examine irritable bowel syndrome as long...

Researchers with the ongoing Arizona CoVHORT research study at the University of...

True progression or pseudoprogression in glioblastoma p...

MIAMI, FLORIDA (STRICTLY EMBARGOED UNTIL SEPT. 29, 2023 AT 5PM ET) – Is it true ...

Synergistic work of cations in anion exchange membranes...

Anion exchange membrane fuel cells (AEMFCs) have gained attention in the process...

Takeda Wagers $580M on AcuraStem’s ALS Treatments

As scientific investigations in the current year persist in highlighting the PIK...

Gilead Abruptly Halts Phase 3 Leukemia Trial Following ...

Another failure has befallen the immuno-oncology wager that Gilead Sciences plac...

Roche pays Ionis $60 million for RNA-targeting Alzheime...

After facing obstacles in its Alzheimer’s trials for gantenerumab the previous y...

FDA approves RYZUMVI for pharmacologically-induced mydr...

Viatris Inc. and Ocuphire Pharma, Inc. have received the go-ahead from the U.S. ...

AI is a pillar of tomorrow’s healthcare system, but lim...

At the industry crossroads of healthcare and pharmaceuticals at the Life Science...

Amicus receives FDA approval for Pompe disease therapy

Amicus Therapeutics has received approval from the US FDA for the two-component ...